Texas

LATEST FROM BIOSPACE
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.
cellvie Inc., the leader in Therapeutic Mitochondria Transfer (TMT) and a Harvard University spin-off, closes a $5M round to advance its product pipeline, including a first application in rejuvenation.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
The lessons learned from the global pandemic are expected to translate to existing and emerging therapeutic areas - particularly oncology; more efficient regulatory-industry relationships; mRNA is a word we will continue to hear a lot about; and home health care is here to stay.
Regulating the activity of the protein called NF-kappa B-inducing kinase (NIK) is emerging as a new and potentially important way to enhance certain immuno-oncology therapies.
Morrisville, North Carolina, has reason to hope that it may be the beneficiary of Fujifilm’s next major investment, a $2 Billion USD large-scale cell culture manufacturing site which the company said will be located near one of its current facilities.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
PRESS RELEASES